Stocktoria
Processa Pharmaceuticals, Inc. PCSA
Processa Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | 100.0% |
| Operating margin | — | — | — | — | — | — | — | — | — | -38430.4% |
| Net margin | — | — | — | — | — | — | — | — | — | -38341.3% |
| FCF margin | — | — | — | — | — | — | — | — | — | -43576.2% |
| Return on assets | -173.6% | -367.0% | -192.2% | -318.2% | -43.2% | -57.2% | -30.9% | -30.2% | -62.2% | -81.1% |
| Return on equity | -243.2% | -698.6% | -222.9% | -367.1% | -44.8% | -62.8% | -41.9% | -38.8% | -497.5% | 84.6% |
| Current ratio | 2.54 | 1.23 | 7.71 | 8.40 | 18.87 | 13.27 | 0.85 | 3.13 | 1.14 | 23.92 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.